Dhuwit awis perusahaan: Syros Pharmaceuticals (SYRS)

SYRS (Syros Pharmaceuticals, Inc.) - tandha merek perusahaan

Geopolitical instability and the severance of scientific ties are hindering the innovative developments of Syros Pharmaceuticals (SYRS). The cash reserve trend captures this decline, where the value of 0.00 corresponds to the current metric. Syros Pharmaceuticals (SYRS) is currently struggling with a cash deficit and is reducing headcount following program failures. However, the success of future genetic research will ensure the monopoly sale of molecules with maximum operating leverage.

Syros Pharmaceuticals Inc. - Gunggung dana dhuwit perusahaan SYRS (periode 04.07.2022 - 29.03.2025)

Rincian metrik lan analitis perusahaan Syros Pharmaceuticals, Inc. (SYRS)

- indikator kapitalisasi bursa perusahaan:
Analisis komprehensif perusahaan:SYRS Syros Pharmaceuticals
Produk merek syros.com

For the biotech startup Syros Pharmaceuticals (SYRS), liquidity levels determine the survival horizon prior to drug commercialization. This metric aggregates cash and cash equivalents, measuring the company's ability to fund R&D without external borrowing. By analyzing the company's cash dynamics, an investor assesses the risk of share dilution during secondary offerings. Amid intense competition with pharma behemoths, this reserve serves as a defense against acquisition. Sufficient capital guarantees the autonomy of developing unique therapy methods.

Perusahaan pesaing

Volume dana dhuwit perusahaan TEM|QGEN - Cadangan dhuwit perusahaan|ionispharma.com - Dhuwit awis perusahaan|Sisa dhuwit perusahaan RGEN|Avidity Corp - Volume dana dhuwit perusahaan|CRISPR Therapeutics Corp - Gunggung dana dhuwit perusahaan|GeneDx Holdings (WGS) - Dana dhuwit perusahaan|Ultragenyx Pharmaceutical (RARE) - Volume dana dhuwit perusahaan|Dhuwit awis perusahaan BEAM|Sarepta (SRPT) - Aset likuid perusahaan|Dana dhuwit perusahaan Twist Bioscience Corp (TWST)|10x - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan NTLA (intelliatx.com)|Gunggung dana dhuwit perusahaan STOK (stoketherapeutics.com)|BioLife Solutions Inc - Volume dana dhuwit perusahaan|WVE (Wave Life Sciences Ltd) - Dhuwit awis lan setara dhuwit awis perusahaan|Maze Therapeutics Corp (MAZE) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan SION|PRME (Prime Medicine Inc) - Volume dana dhuwit perusahaan|Taysha Gene Therapies (TSHA) - Aset likuid perusahaan|Dhuwit awis perusahaan QURE (uniqure.com)|Gunggung dana dhuwit perusahaan MGTX|Volume dana dhuwit perusahaan RGNX (regenxbio.com)|SLDB: Dhuwit awis lan setara dhuwit awis perusahaan|ocugen.com - Volume dana dhuwit perusahaan|PACB - Volume dana dhuwit perusahaan|BNTC: Volume dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan DSGN|Dana dhuwit perusahaan Rocket Pharmaceuticals|Dhuwit awis perusahaan 4DMT (FDMT)|Volume dana dhuwit perusahaan LXEO|Aset likuid perusahaan Korro Bio Inc.|Volume dana dhuwit perusahaan EDIT (Editas Medicine Inc)|SLN: Dhuwit awis lan setara dhuwit awis perusahaan|PRQR - Dana dhuwit perusahaan|Aset likuid perusahaan codexis.com CDXS|SGMO: Volume dana dhuwit perusahaan|Nautilus Biotechnology (NAUT) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Metagenomi, Inc|precisionbiosciences.com (DTIL) - Aset likuid perusahaan|Dana dhuwit perusahaan Generation Bio Co. (GBIO)|Aset likuid perusahaan Boundless Bio, Inc.|Dana dhuwit perusahaan Exicure, Inc. XCUR|IMNN: Dhuwit awis lan setara dhuwit awis perusahaan|PHIO - Dana dhuwit perusahaan|Aset likuid perusahaan Mustang Bio MBIO|RNAZ: Volume dana dhuwit perusahaan|Posisi dhuwit perusahaan Bionano Genomics Inc. BNGO|APDN (Applied DNA Corp) - Volume dana dhuwit perusahaan|bluebirdbio.com (BLUE) - Aset likuid perusahaan|Volume dana dhuwit perusahaan IPA|Volume dana dhuwit perusahaan Omega (OMGA)|Dana dhuwit perusahaan Singular Genomics Systems Inc OMIC|Volume dana dhuwit perusahaan Regulus RGLS|Telesis Bio, Inc. - Volume dana dhuwit perusahaan|TRACON Pharmaceuticals (TCON) - Dhuwit awis perusahaan|UBX: Volume dana dhuwit perusahaan